NMR in Biomedical Research
Junxia Lu (lujunxia at yahoo dot com)
Pacific Northwest National Laboratory, United States
DOI
//dx.doi.org/10.13070/mm.en.3.170
Date
last modified : 2024-08-25; original version : 2013-02-12
Cite as
MATER METHODS 2013;3:170
Introduction

Nuclear magnetic resonance (NMR) is a spectroscopic technique to study molecules with NMR active nuclei. Not all nuclei can give NMR signals. Only those nuclei possessing non-zero nuclear spin (I¹0) have a nuclear magnetic moment which produces magnetic interactions with an external magnetic field. Sitting in an external magnetic field, the NMR active nucleus would have energy level splitting. A radio frequency pulse of the right frequency would induce transitions of nuclei from the lower energy levels to the higher energy levels. After the radio frequency pulse is switched off, the nucleus at the higher energy states would relax back to the lower states, giving out signals (figure 1). This is called the nuclear Zeeman Effect. Since the energy level splitting is different for different atomic nuclei, for a fixed external magnetic field, the frequency of the signal becomes a characteristic for a specific atom (Larmor frequency). Atoms such as 1H, 2H, 13C, 15N, 31P, etc. are the common nuclei studied using NMR in biomedical research.

NMR in Biomedical Research figure 1
Figure 1. The basics of NMR. The nuclear energy level splits in an external magnetic field Bo. The splitting DE is determined by the field strength Bo and nuclear gyromagnetic ratio γ. The radio frequency pulse induces a transition of nuclei from the low energy level to the high energy level. The nuclei at the high energy level (excited state) would relax back to the low energy level and give out NMR signals.

NMR is a powerful technique applied in a variety of field, especially in biomedical research. NMR can identify molecules, to probe molecular dynamics and study the molecular interactions. In biomedical research, it has been applied to the structure and function determination of important biological molecules, such as drug targets; study of drugs and the interactions with their targets; identification of abnormal metabolites as the biomarkers for specific diseases; diagnoses of disorders by imaging particular tissues or organs. For example, L Pellegrini et al measured the levels of L-Dopa and Dopa through NMR analysis in choriod plexus organoid fluid [4]. Ting CP et al ascertained the structures of reactants and amino acid-derived products of a novel biosynthetic pathways through 1H, 13C, and 31P NMR analyses [5]. Kim TH et al probed the interactions within pFMRP-CAPRIN1 biological condensates with solution-state NMR spectroscopy [6].

If there were only nuclear Zeeman interaction in NMR, NMR would not be as powerful as it is. There are five major NMR interactions besides Zeeman interaction [7], including chemical shift, scalar coupling (J), dipolar interaction, paramagnetic interaction (if a paramagnetic nucleus is involved) and quadrupolar interaction (if quadrupolar nucleus with I>1/2 is involved). These interactions are susceptible to the molecular motion and the chemical environment (such as chemical bonding and atoms spacial arrangement, etc.), affecting the position, intensity, and splitting of NMR peaks (figure 2). The size and the motion of the molecules also affect NMR relaxation properties, which are fully exploited in NMR research too. For example, water relaxation behavior in tissues has been utilized in magnetic resonance imaging (MRI) to take images of different parts of the body [8].

NMR in Biomedical Research figure 2
Figure 2. (a) A simplified illustration of one NMR peak at nuclear Larmar frequency. However, the NMR peak position is affected by other factors such as its electronic environment and bonding. (b) The same nucleus from two groups (e.g., H from -CH2- or -CH3 groups) would have different NMR peak positions. (c) The NMR peaks would have further splittings and shifts caused by other NMR interactions such as scalar (J) coupling, etc.
NMR Application in Biomedical Research
Structural biology: structural and dynamic characterization of macromolecules

From the macromolecular level, the main building blocks of our body are composed of proteins, nucleic acids, lipids and carbohydrates [8]. Proteins have functions such as transporting molecules or ions across the cell membranes, transducing signals, or carrying out biochemical reactions, etc. Proteins could also be the structural basis of our body, like muscles. Nucleic acids (DNA, RNA) store our genetic information and can function in a complicated scheme to deliver this information from cells to cells and from one generation to the next. Lipids form the structural basis of the organelles, cells, organs and other body compartments membrane surface. Carbohydrates take part in a lot of metabolic processes and are our main source of energy. Carbohydrates, usually conjugated with lipid membranes or proteins, also play important roles in cell recognition and other specific functions. These macromolecules also have the same importance in bacteria or viruses, which are the common pathogen for us. The structure and dynamics of these macromolecules and their complex determine their functions. This information is fundamental to most of our medical problems. NMR provides specific advantages in determining the structure and dynamics of macromolecules. 1H, 12C, 14N, 16O and 31P nuclei are the main nuclei species composing of these macromolecules. In this group, 12C and 16O are not NMR active nuclei and 14N is the quadrupolar nucleus, not commonly studied. Usually, isotopic labeling is applied to replace 12C and 14N nuclei in these molecules to NMR active 13C and 15N to facility NMR study.

The importance of using NMR to solve biological macromolecular structures has been recognized by awarding Nobel Prize in chemistry to Kurt Wüthrich in 2002. Wüthrich and co-workers developed NMR techniques to allow them to determine the first solution-state NMR protein structure in 1984. And after that, NMR techniques have progressed dramatically towards solving structures for bigger and more complex biological molecules [9] and high-throughput structure determination. Although there are varieties of organic molecules able to be studied by NMR, in this article, the discussion is mainly focused on the structural study of proteins.

Protein structural determination using solution NMR

Proteins account for more than 75% of the currently known drug targets. Some proteins are also developed as drugs to supplement to the body. The knowledge of the structure of a particular protein can help us understand how it achieves its specific function and how to fix the problems when something goes wrong. As of May 16, 2020, there are more than 163949 protein structures deposited into the protein data bank (PDB) [10]. Most of the structures are solved by x-ray crystallography. Less than 10% of the structures are solved by NMR (12983 structures), especially solution NMR. However, solution NMR still offers some particular advantages over crystallography. For example, Kitchen P et al determined the conformational change in the AQP4 carboxyl terminus caused by calmodulin binding [11]. Rice HC et al determined the binding of the APP 9-mer to the GABABR1a sushi 1 domain with NMR [12]. Solution NMR does not require the proteins to form crystals, which may be problematic for some proteins. By studying proteins in solution, the proteins are provided with an environment strictly mimicking their physiological state and are allowed to have their natural dynamics as well.

Looking into the molecular details, proteins are biopolymers formed by 20 different amino acids organized in different orders and into various lengths (figure3) [13]. Because of the sequence differences, the proteins would organize and form a variety of 3-dimensional structures. The structural difference would affect the atomic electronic environment, causing the atomic chemical shifts dispersion. Statistically, people have summarized the relationship between the protein secondary structures (α-helix, β-sheet, random coil secondary structures) and 1H, 13C, 15N chemical shifts for the 20 different amino acids [14].

NMR in Biomedical Research figure 3
Figure 3. Schematic representation of protein sequence formed by connecting different amino acids through peptide bonds. The real protein conformation is not a linear chain shown here, but a 3-dimensional structure.

It is not a trivial task to assign each chemical shift (peak) to a specific atom at specific amino acid (residue) for proteins because the one-dimensional spectra are often crowded (figure 4). One way to partially overcome this problem is to use a higher field NMR instrument. For protein NMR, it is good to obtain an NMR spectrum at a higher field because higher field offers higher resolution and sensitivity. With the development of multi-dimensional NMR techniques, the correlations between neighbor atoms or residues can be detected [15]. These correlations greatly facilitate the sequential assignment of proteins, which is the first step in solving a protein structure using NMR. Usually, these correlations are obtained through J coupling interaction between neighboring atoms or through some relaxation mechanisms.

NMR in Biomedical Research figure 4
Figure 4. A 13C NMR spectrum of uniformly 13C isotopically labeled protein amelogenin at an 11.75 T magnet using Varian (Agilent) NMR instrument.

Although chemical shifts alone have been used to predict the protein secondary structures, a lot more structural constraints are needed to build the full structure of a protein. And those constraints are obtained utilizing the NMR interactions, such as scalar coupling or dipolar coupling interactions or relaxation mechanism. Karplus relation predicts the dependence of three-bond scalar coupling values (3J) to the molecular dihedral angles [16]. RDC (residue dipolar coupling) is a technique to obtain the dipolar coupling value of 15N-1H or 13C-1H of proteins in a weak alignment medium, which could help us to figure out the orientation of these bonds with respect to the molecular alignment axis [17]. 1H-NOE (nuclear Overhauser effect) is used to measure the distance between two nuclei up to 5 Å. The cross-relaxation causes it through intra-molecular dipole-dipole interactions between the two nuclei [18].

The final protein structures are often obtained by running a simulated annealing process, such as Xplor-NIH [19], with all the chemical shifts assignments and structural constraints. After several geometry optimizations and structural refinements, an ensemble of molecules with similar structures would be generated. And the average of these structures would be used to present the final protein 3-dimensional structure.

One example given here is the study on phospholamban, a protein in the sarcoplasmic reticulum (SR) membrane of cardiomyocytes that could regulate the intracellular calcium level, affecting the contraction and relaxation of heart muscle cells. Calcium ATPase in the SR membrane is responsible for pumping calcium from the cytoplasm into the SR. The monomeric form of phospholamban can bind to calcium ATPase and inhibit its function. Phosphorylation of phospholamban relieves the inhibition. Mutations in phospholamban could cause dilated cardiomyopathy and heart failure [20]. Solution NMR has been used to study the structure of phospholamban and its variants (figure 5) [21, 22]. NMR distance and dihedral angle constraints were used as inputs in Xplor, and the final structural ensemble was generated. The structures obtained have been used to predict the binding mode between phospholamban and calcium ATPase and to explain why specific mutations are critical in phospholamban’s function [23].

NMR in Biomedical Research figure 5
Figure 5. A selection of structures of phospholamban incorporated into the phospholipid membranes. The figure was produced using MOLMOL. The two solution NMR structures were generated according to the structural coordinates deposit in the protein data bank. The solid-state NNR structure was generated from the information obtained in the literature [1].

Also, a combination of NMR spectroscopy, small-angle X-ray scattering and mutagenesis has been used to generate AlphaFold models of Rec114-Mei4 and Mer2 complexes [24]. The study characterized the activation of the assembly of the meiotic DSB machinery by Rec114-Mei4 and Mer2 complexes. Furthermore, Mer2 condensation was shown to be the main regulator of the assembly, which was also supported via Rec114-Mei4. Another study applied magnetic resonance, mass spectrometry and small-angle scattering data to verify the solution structure of the polypyrimidine-tract binding protein 1 (PTBP1/hnRNP I) binding to the internal ribosome entry site (IRES) of the encephalomyocarditis virus (EMCV) [25]. The atomic-level analysis of RNP structures showed that this binding induces RNA and protein compaction with pronounced conformational flexibility. It was also revealed that PTBP1 induces the generation of several IRES RNA conformations.

Protein structural determination using solid-state NMR

Solid-state NMR is different from solution NMR in that the sample used in solid-state NMR is in the solid or semi-solid form. More than half of our body mass is water. Therefore, a lot of biochemical reactions take place in solution phase. However, there are still certain situations when the studies have to be carried out during the solid-state phase. There are solid tissues like bones, teeth, the structure of which could also be understood with the help of NMR. There are molecules embedded in the biological membranes. Membranes are in gel-like semi-solid form. Most protein drug targets are membrane proteins [26]. They usually act as receptors or transporters to pass the information or molecules in and out of the membranes. Not only in human being, but there are also interesting solid-state protein structures in bacteria and viruses too. For example, the virus capsid (the virus shell) formed by capsid proteins has a unique structure with high symmetry. HIV capsid protein has been a hot topic in solid-state NMR field [27]. The information gathered from the structural study will help us towards a cure for AIDS. Solid-state NMR is necessary to study those proteins while keeping them in the native environment.

The solid or semi-solid form of samples has very different molecular dynamics from their solution state. The molecule in the solid phase has restricted motions, and becomes anisotropic, causing a significant change in the properties of the NMR interactions [28]. The chemical shift becomes chemical shift anisotropy. The chemical shift is orientation dependent and is slightly different for each molecule with a different orientation, causing the broadening of the peaks. The dipolar or quadrupolar interaction increases in the magnitude because of less motion average. The broad lineshape makes the NMR spectrum more difficult to obtain and interpret. There are two ways to circumvent this line broadening problem in solid-state NMR. One way is to align the molecules so that all the molecules in the sample have a similar orientation. This technique has been applied to studying membrane proteins [29]. Phospholipids bilayer membranes can be aligned in the magnetic field mechanically or magnetically; the proteins embedded in the membrane are thereby aligned as well. The protein molecules in the aligned sample have similar chemical shifts and narrower linewidths. The other way is to fast spin the sample at an angle of 54.74◦ with the external magnetic field. This angle is called the magic angle. At this angle, these orientation-dependent NMR interactions are averaged to minimum mathematically [30] (figure 6). Besides these, strong 1H decoupling has been commonly used to reduce the linewidth caused by large dipolar interactions between 1H and other diluted spins [31]. Cross-polarization between 1H and other diluted spins is an efficient way to enhance the signals of the diluted spins [32].

NMR in Biomedical Research figure 6
Figure 6. (a) The molecules in the sample have a random orientation. (b) The molecules in the sample are all aligned in one direction. (c) The sample rotor (the sample holder) has fast spinning motion around an axis which has an orientation of 54.74◦ (θ) with the external magnetic field (Bo).

The general strategy to solve a protein structure using solid-state NMR is similar to solution NMR. The assignment of chemical shifts to the corresponding protein residues is needed first. The distance and orientation constraints have to be obtained as many as possible. The NMR interactions are orientation and distance dependent, giving the opportunities to acquire the structural constraints. The final structure is also generated with the help of simulation programs.

Phospholamban is also a perfect candidate for the solid-state NMR study because it is a membrane protein and most of its interaction partners are membrane proteins too. Interestingly, the structure of phospholamban revealed by solid-state NMR in the phospholipid environment (figure 5) is similar but still somehow different from that obtained using solution NMR techniques purely, showing the complexity of a real structural biology problem [21-23, 33]. Solid-state NMR was also sued to study the structural properties of the toxic and non-toxic types of α-synuclein oligomers [34].

Alzheimer’s disease (AD) is the most common neurodegenerative disease and the 6th leading causing of death in the US. It has been linked to the unusual protein deposit in the brain (brain plaques). The main component of the brain plaques is amyloid fibrils formed by β-amyloid peptide (Aβ). To understand the amyloid fibril structure is fundamental to understanding the cause of this disease. Solid-state NMR has been very successful in solving this structural problem (figure 7) [35, 36]. Fast magic angle spinning techniques have been applied to the fibril samples. A lot of dipolar recoupling methods have also been developed to gain distance constraints of the protein fibrils [37, 38].

NMR in Biomedical Research figure 7
Figure 7. (Left) Transmission electron microscopy image of an Abeta fibril derived from human brain with Alzheimer’s disease. (Right) Structure model of the fibril shown on the left generated mainly using solid-state NMR constraints. The figure was produced using MOLMOL.

The structure of aquaporin Z (AqpZ) by ssNMR in Escherichia coli inner membranes was revealed using solid-state NMR [39]. The study applied 1017 distance restraints obtained from two-dimensional 13C-13C spectra to verify the 1.7-A ssNMR structure of AqpZ in E. coli inner membranes. To increase the signal sensitivity of AqpZ, outer membrane components were removed. Furthermore, antibiotics were added to diminish the interference of background proteins. Solid-state NMR spectroscopy was used to analyze the specific tau filament isoforms and demonstrated that amyloid fibrils consisting of acetylated three-repeat tau varied in composition, suggesting that site-specific acetylation affects tau structure [40]. The study indicated that acetylation regulates the aggregation of three-repeat tau in neurodegenerative diseases.

Pharmaceutical research: drug screening

With the development of technology, a huge number of low molecular weight compounds have been synthesized by the chemists and a large number of biological targets have been characterized by the biologist. These compounds and their derivatives are the potential drugs. High-throughput screening is needed to pick up the right pairs, the compound (as a ligand for its target) and its interacting target, often proteins or nucleic acids. Hopefully, this compound could also intervene with the action of the target in vivo, leading to drug discovery. The understanding of the structure of the target and the compound, the target-ligand complex and the interaction mechanism could help in improving the drug design. NMR is one of the tools that could be used here for the discovery.

NMR, especially solution NMR has been widely applied in chemical synthesis as an analytic tool to identify compounds, for example, chemical syntheis of QC-01–175, a tau protein degrader [41], and biocatalytic manufacture of islatravir [42], among others [43]. Many organizations have built and maintained vast and comprehensive NMR spectra databases (e.g., www.acdlabs.com). NMR could also be a structure elucidation tool for those biological targets or target-ligand complexes, as discussed in the last section. Biological magnetic resonance databank is one of the places where a lot of structures of biological macromolecules are deposited [44]. Furthermore in pharmaceutical research, NMR has also been developed to fast screen the potential drug compounds, lead generation and optimization, namely detecting the ligand binding to their biological macromolecular targets, locating the active sites, measuring the affinity or the kinetics of the binding and optimizing the structure of the ligands based on the results [45, 46].

Using Alzheimer’s disease as an example again, the fibril-forming peptide Aβ is produced when the Abeta precursor protein is sequentially cleaved by two proteases, one of which is called β-secretase (BACE) [47]. BACE is a transmembrane aspartyl protease. The inhibition of BACE is a very promising approach for the treatment of Alzheimer’s disease [48]. Fragment-based NMR screening was applied on a custom-built fragment library of approximately 10000 compounds to identify small molecules that could bind and inhibit the function of BACE [2]. First 1H-15N HSQC 2 dimensional NMR experiment of BACE was carried out with or without adding the small molecules (figure 8). A comparison of the chemical shift for each site gave the information whether the binding occurred and where the binding site was. A chemical shift perturbation was expected for the protein active sites once the binding happened. Several lead compounds were identified. The dissociation constants Kd were also measured by integration of corresponding residue NMR peaks as a function of the lead compound concentrations [49]. With the help of other structural analysis (such as X-ray crystallography) along with NMR, a close study of the structure of the protein active sites, as well as the interaction with the small molecule, further indicated the direction of lead compound optimization [2].

NMR in Biomedical Research figure 8
Figure 8. (Left) Selected regions of 2D 15N-HSQC spectra measured with a sample of 100 µM uniformly 15N-labeled BACE-1 alone (black), in the presence of 27.5(cyan), 55(magenta), 110(blue), 220(green) and 440(red) µM of a hit compound shown on the right. The chemical shifts change at two aspartates sites (Asp32, Asp228), indicating the hit compound binding location [2]. The figure was reproduced with the copyright permission from ACS.

The NMR drug screening could also be done by observation of the ligand resonance changes. The binding of a small molecule to a macromolecule would make the small molecule behave like a macromolecule, causing a significant change in its dynamics. The chemical shift would be perturbed, the linewidth would be broader, and the molecular NMR relaxation properties would be altered too [50].

In addition, photochemically induced dynamic nuclear polarization (photo-CIDNP), the only NMR method directly applicable in aqueous solution, was used to identify weak binders using low micromolar concentrations of target molecules [51]. The interaction was analyzed by single-scan NMR experiments with a duration of 2 to 5 seconds. Also, samples were evaluated using an automated flow-through platform. Moreover, the obtained data included a 212 compounds photo-CIDNP fragment library.

Metabolomics: NMR study of metabolites

Metabolites are the intermediates or final products of different biochemical reactions happening in a biological system. Metabolomics is a subset discipline of systems biology where the metabolites from a specific biological system are assessed, identified and quantified to gain information about the functional state of that biological system. Theoretically, it can be used as an early diagnostic tool for diseases. The malfunction of the biological system will cause a disorder in the metabolites. NMR is the best tool to analyze this kind of complex samples, second to Mass Spectrometry [52]. Most of the time, the NMR sample is some biofluids like urine, blood or other fluid from the body. With the introduction of the stronger magnetic fields and better probe designs (cryo-cooled NMR probes or high-resolution magic-angle-spinning probe, etc.), both the sensitivity and resolution of NMR have increased enormously. NMR is, therefore, able to identify the biomarkers or pick up the fine “fingerprints” in the micromolar concentration range in the full spectrum of the biofluids, correlating them with certain diseases.

However, metabolites from a particular biological system are usually complicated and multivariate. Therefore, using NMR as a diagnostic tool for diseases is still mostly at the research stage. Skipping the detail procedure for the sampling and NMR sample preparation, the NMR spectrum is usually taken in a straight forward way as mentioned above. A one-dimensional 1H-NMR spectrum of the sample would be the first step. A two-dimensional spectrum using correlation spectroscopy (COSY) or other NMR pulse techniques could be used to help identify the components. The spectra of the biofluid samples from multi-groups and the control have to be compared. It is important to know that the analysis and comparison of the spectra are not done in a straight way. Instead, it is done using systematically statistical analyses because of the complexity of the spectra [53].

As example, NMR has been used to identify potential diagnostic biomarkers in Alzheimer’s disease (AD) [54] or the metabolome profiling related to microbiome in irritable bowel syndrome [55]. 1H-NMR spectroscopy and multivariate statistical methods were used to compare the metabolomics profiles of different brain regions in the wild-type mice and transgenic mice having AD-like symptoms [54]. One significant metabolic change was a decrease in N-acetyl-L-aspartate (NAA), developed even before the appearance of the clinical symptoms in transgenic mice [56].

High-resolution magic angle spinning nuclear magnetic resonance (HRMAS NMR) spectroscopy was used to evaluate cellular metabolism in Clostridioides difficile [57]. The study found recruitment of oxidative and supporting pathways combined with integration of high-flux amino acid and glycolytic metabolism. High-resolution analysis of living cells in small reaction volumes was suggested to be a significant advantage of HRMAS NMR compared to alternative MNR techniques.

Magnetic resonance imaging (MRI) or magnetic resonance spectroscopy (MRS) of body and tissues

Lauterbur and Mansfield first illustrated the principle of acquiring two dimensional (2D) and three dimensional (3D) images using NMR in 1973. After that, MRI has been developed and become perhaps mostly known NMR techniques by the public since they are widely used in clinical diagnosis and preclinical research. Imagines or spectra could be obtained for part of the body of a living subject noninvasively. Lauterbur and Mansfield were awarded the Nobel Prize in Medicine in 2003 for their significant contribution to medical science.

The NMR frequency of a specific nucleus is related to the strength of the external magnetic field. For the research mentioned in the above sections, the sample is usually required to be kept in a homogenous magnetic field to make the NMR peak linewidth as narrow as possible. In MRI, however, the field gradients are purposefully introduced across the sample, so that the NMR frequency of the nucleus at different positions in the sample is slightly different and the difference information is used to map the location of the nucleus in the sample (figure 9).

NMR in Biomedical Research figure 9
Figure 9. The simplified MRI imaging principle. A magnetic field gradient is applied along the x-axis (Gx). Therefore, the magnetic field strength in the z-direction is different for different positions at the x-direction. If an NMR spectrum (e. g. 1H NMR) is taken for the triangle piece put in the magnetic field, the NMR frequency is proportional to the strength of the field and would be correlated to the position of the triangle piece along the x-axis. The NMR peak intensity is related to the 1H spin density at the specific position.

For MRI, a 2D or 3D image is taken for a particular section of the body. By applying magnetic field gradients across all three directions (x, y, z in a Cartesian coordinate), a proper section of the body can be selected. Usually, the 1H NMR signal contributing mainly from water and fat abundantly in the body is obtained for the imaging. The contrast of the images depends on a combination of several factors such as the nuclear spin density (1H spin density for 1H NMR), nuclear spin-lattice relaxation (T1) and nuclear spin-spin relaxation (T2), etc. (figure 10). The images could help us identify tumors or blood clot or other abnormality in the body.

NMR in Biomedical Research figure 10
Figure 10. Examples of MRI of axial images of brain (A) FLAIR image (FLAIR is a pulse sequence technique used in MRI to suppress the signals generated by fluids in the body); (B) T1-weighted postcontrast image [3]. The figure was reproduced with the copyright permission from Wiley.

For MRS, a one-dimensional spectrum of a particular location of the body is obtained (in the order of 1 mm3) by using the magnetic field gradients in x, y, z three directions [58]. 1H nucleus as well as other nuclei such as 31P, 19F, 13C has been studied. Since a spectrum is taken, the chemical shift information could be obtained to distinguish different species. Therefore MRS has been applied in metabolites study in vivo for the diagnostic purpose. Although there are hundreds and thousands of metabolites in the body, MRS can observe only a few with very high concentration. To get a better resolution and a higher sensitivity, a higher magnetic field is preferred than MRI. In brain MRS, the commonly observed metabolites are N-acetyl aspartate (NAA), creatine (Cre), and choline (Cho), etc. [59]. NAA has been referred to as a neuronal marker; creatine and choline are also groups of molecules that are involved in energy and membrane metabolism pathways. Because the spectrum is obtained for various locations, the 2D or 3D spectroscopic image using a specific chemical shift corresponding to a metabolite could also be generated telling us the distribution of the metabolite in the tissue [60].

As an example, MRI and MRS have also been used in Alzheimer’s disease to diagnose and monitor the treatment of this disease [60, 61]. Shrinkage of the brain volume and tissue loss in specific brain regions, such as the hippocampus and temporal lobes, are useful to predict the disease at the early stage. The decrease of the brain atrophy rate could be used to monitor the treatment effect of newly developed anti-AD drugs. The relative concentration changes of some MRS detectable metabolites such as NAA, creatine, and choline have been studied and proved to be useful in the diagnosis of AD [60].

A variation of MRI is the functional MRI, which studies the metabolic process. It is discussed in more detail here.

Recent advances in magic-angle spinning (MAS) NMR

Significant progress has recently been achieved in the development of magic-angle spinning (MAS) NMR. This method allows the identification and characterization of protein complexes, such as transmembrane proteins [62] and metalloproteins [63] and provides both structural and dynamical characteristics of the target molecules. MAS NMR identified structural details at the atomic level for T3SS [64], DsbB [65] and FimA [66] proteins.

Regarding the protein dynamics, MAS NMR may be applied to evaluate the activity of multiple regions within a protein complex synchronously. In particular, this method helped to analyze enzymatic catalysis [67] and interactions within protein agglomerates [68]. In addition to protein complexes, MAS NMR was used for analysis of nucleic acids [69] and nucleic acid-protein interactivity [70].

Concerning studies of protein complexes, MAS NMR is also useful for analysis of molecular interactions within cellular membrane, cytoskeleton components, and activity of viral proteins. For instance, this technique was suggested to be used for structural analysis of complexes formed by microtubules and associated small molecules [71, 72].

Also, MAS NMR is an effective method to investigate structural and functional aspects of viral protein complexes, especially when it is combined with crystallography or in silico simulations. In particular, it was used to study functions and conformational modifications of Cyclophilin A, a human protein which forms a complex with HIV capsid and affects HIV-1 infectivity [73]. Also, MAS NMR was recommended for structural and functional analysis of bacteriophage proteins [74, 75].

Solid-state MAS NMR was used to investigate ssDNA-bound conformation in F-specific filamentous phages [76]. The study described the structure of the gVp monomer bound to the ssDNA of fd phage in the nucleoprotein complex. The generated model showed significant conformational changes concerning the free form. These changes affect the binding mechanism and potentially activate cooperative binding in the gVp-ssDNA complex.

Summary

NMR is a fast progressing field having a tremendous impact on the biomedical research. Some of the applications are only at the beginning of their developing stage. This article only discussed some basic and widely applied approaches utilized in the research. At the same time, all the different researches also promote the hardware of the instrument to improve too. In 1995 , the first bruker 800MHz NMR magnet was made, which was very big in size and costly in maintenance and usage. Right now it has become the common instrument for protein NMR research to solve the structures of big protein molecules. NMR needs scientists and engineers from all fields to work together to promote the development of this technique.

FieldsStudy materialInformationExamples
Structural biologyBiological macromoleculesStructures and dynamicsMembrane protein phospholamban related to cardiomyopathy
Amyloid fibrils from Alzheimer’s disease
Drug screeningPotential drug molecules and its biological targetsThe interactions between the drug and its targetPotential drug for Alzheimer’s disease
MetabolomicsBiofluidsAbnormal metabolitesBiomarkers for Alzheimer’s disease
Medical imagingBody or tissues (in vivo)Abnormal structures or metabolites in the body or tissueBrain imaging or spectra for a particular region of brain to diagnose Alzheimer’s disease, for example, [77]
Table 1. A summary of NMR applications in biomedical research, the information to obtain and examples discussed in this article.
References
  1. Andronesi O, Becker S, Seidel K, Heise H, Young H, Baldus M. Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy. J Am Chem Soc. 2005;127:12965-74 pubmed
  2. Wang Y, Strickland C, Voigt J, Kennedy M, Beyer B, Senior M, et al. Application of fragment-based NMR screening, X-ray crystallography, structure-based design, and focused chemical library design to identify novel microM leads for the development of nM BACE-1 (beta-site APP cleaving enzyme 1) inhibitors. J Med Chem. 2010;53:942-50 pubmed publisher
  3. Sung V, Lyerly M, Fallon K, Bashir K. Isolated CNS Whipple disease with normal brain MRI and false-positive CSF 14-3-3 protein: a case report and review of the literature. Brain Behav. 2012;2:838-43 pubmed publisher
  4. Pellegrini L, Bonfio C, Chadwick J, Begum F, Skehel M, Lancaster M. Human CNS barrier-forming organoids with cerebrospinal fluid production. Science. 2020;: pubmed publisher
  5. Ting C, Funk M, Halaby S, Zhang Z, Gonen T, van der Donk W. Use of a scaffold peptide in the biosynthesis of amino acid-derived natural products. Science. 2019;365:280-284 pubmed publisher
  6. Kim T, Tsang B, Vernon R, Sonenberg N, Kay L, Forman Kay J. Phospho-dependent phase separation of FMRP and CAPRIN1 recapitulates regulation of translation and deadenylation. Science. 2019;365:825-829 pubmed publisher
  7. Chary KVR, Govil G. Basic Concepts In NMR Spectroscopy. In: Chary KVR, Govil G, editors. NMR in Biological Systems: Springer Netherlands; 2008. p. 1-41.
  8. Lascialfari A, Corti M. Basic concepts of Magnetic Resonance Imaging. NMR-MRI, μSR and Mössbauer Spectroscopies in Molecular Magnets: Springer Milan; 2007. p. 89-110.
  9. Zhu G, Xia Y, Lin D, Gao X. TROSY-based correlation and NOE spectroscopy for NMR structural studies of large proteins. Methods Mol Biol. 2004;278:57-78 pubmed
  10. RCSB PDB. Available from: www.rcsb.org/
  11. Kitchen P, Salman M, Halsey A, Clarke Bland C, MacDonald J, Ishida H, et al. Targeting Aquaporin-4 Subcellular Localization to Treat Central Nervous System Edema. Cell. 2020;181:784-799.e19 pubmed publisher
  12. Rice H, de Malmazet D, Schreurs A, Frere S, Van Molle I, Volkov A, et al. Secreted amyloid-β precursor protein functions as a GABABR1a ligand to modulate synaptic transmission. Science. 2019;363: pubmed publisher
  13. Voet D, Voet JG. Biochemistry: Wiley; 2010.
  14. Wishart D, Bigam C, Yao J, Abildgaard F, Dyson H, Oldfield E, et al. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR. 1995;6:135-40 pubmed
  15. Chary KVR, Govil G. Protein NMR: General Principles and Resonance Assignments. In: Chary KVR, Govil G, editors. NMR in Biological Systems: Springer Netherlands; 2008. p. 163-210.
  16. Minch MJ. Orientational dependence of vicinal proton-proton NMR coupling constants: The Karplus relationship. Concept Magnetic Res. 1994;6(1):41-56.
  17. Lipsitz R, Tjandra N. Residual dipolar couplings in NMR structure analysis. Annu Rev Biophys Biomol Struct. 2004;33:387-413 pubmed
  18. Herrmann T, Güntert P, Wuthrich K. Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol. 2002;319:209-27 pubmed
  19. Schwieters C, Kuszewski J, Tjandra N, Clore G. The Xplor-NIH NMR molecular structure determination package. J Magn Reson. 2003;160:65-73 pubmed
  20. Schmitt J, Kamisago M, Asahi M, Li G, Ahmad F, Mende U, et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science. 2003;299:1410-3 pubmed
  21. Zamoon J, Mascioni A, Thomas D, Veglia G. NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys J. 2003;85:2589-98 pubmed
  22. Traaseth N, Shi L, Verardi R, Mullen D, Barany G, Veglia G. Structure and topology of monomeric phospholamban in lipid membranes determined by a hybrid solution and solid-state NMR approach. Proc Natl Acad Sci U S A. 2009;106:10165-70 pubmed publisher
  23. Oxenoid K, Chou J. The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc Natl Acad Sci U S A. 2005;102:10870-5 pubmed
  24. Daccache D, De Jonge E, Liloku P, Mechleb K, Haddad M, Corthaut S, et al. Evolutionary conservation of the structure and function of meiotic Rec114-Mei4 and Mer2 complexes. Genes Dev. 2023;37:535-553 pubmed publisher
  25. Dorn G, Gmeiner C, de Vries T, Dedic E, Novakovic M, Damberger F, et al. Integrative solution structure of PTBP1-IRES complex reveals strong compaction and ordering with residual conformational flexibility. Nat Commun. 2023;14:6429 pubmed publisher
  26. Drews J. Drug discovery: a historical perspective. Science. 2000;287:1960-4 pubmed
  27. Han Y, Ahn J, Concel J, Byeon I, Gronenborn A, Yang J, et al. Solid-state NMR studies of HIV-1 capsid protein assemblies. J Am Chem Soc. 2010;132:1976-87 pubmed publisher
  28. Chary KVR, Govil G. High-Resolution Solid-State NMR. In: Chary KVR, Govil G, editors. NMR in Biological Systems: Springer Netherlands; 2008. p. 317-49.
  29. Park S, De Angelis A, Nevzorov A, Wu C, Opella S. Three-dimensional structure of the transmembrane domain of Vpu from HIV-1 in aligned phospholipid bicelles. Biophys J. 2006;91:3032-42 pubmed
  30. Andrew ER, Bradbury A, Eades RG. Nuclear Magnetic Resonance Spectra from a Crystal rotated at High Speed. Nature. 1958;182(4650):1659.
  31. Bennett AE, Rienstra CM, Auger M, Lakshmi KV, Griffin RG. Heteronuclear Decoupling in Rotating Solids. J Chem Phys. 1995 Oct 22;103(16):6951-8.
  32. Pines A, Gibby MG, Waugh JS. Proton-Enhanced Nmr of Dilute Spins in Solids. J Chem Phys. 1973;59(2):569-90.
  33. Verardi R, Shi L, Traaseth N, Walsh N, Veglia G. Structural topology of phospholamban pentamer in lipid bilayers by a hybrid solution and solid-state NMR method. Proc Natl Acad Sci U S A. 2011;108:9101-6 pubmed publisher
  34. Fusco G, Chen S, Williamson P, Cascella R, Perni M, Jarvis J, et al. Structural basis of membrane disruption and cellular toxicity by ?-synuclein oligomers. Science. 2017;358:1440-1443 pubmed publisher
  35. Tycko R. Solid-state NMR studies of amyloid fibril structure. Annu Rev Phys Chem. 2011;62:279-99 pubmed publisher
  36. Qiang W, Yau W, Luo Y, Mattson M, Tycko R. Antiparallel ?-sheet architecture in Iowa-mutant ?-amyloid fibrils. Proc Natl Acad Sci U S A. 2012;109:4443-8 pubmed publisher
  37. Tycko R. Symmetry-based constant-time homonuclear dipolar recoupling in solid state NMR. J Chem Phys. 2007;126:064506 pubmed
  38. Hu K, Tycko R. Zero-quantum frequency-selective recoupling of homonuclear dipole-dipole interactions in solid state nuclear magnetic resonance. J Chem Phys. 2009;131:045101 pubmed publisher
  39. Xie H, Zhao Y, Zhao W, Chen Y, Liu M, Yang J. Solid-state NMR structure determination of a membrane protein in E. coli cellular inner membrane. Sci Adv. 2023;9:eadh4168 pubmed publisher
  40. Chakraborty P, Rivi xe8 re G, Hebestreit A, de Opakua A, Vorberg I, Andreas L, et al. Acetylation discriminates disease-specific tau deposition. Nat Commun. 2023;14:5919 pubmed publisher
  41. Silva M, Ferguson F, Cai Q, Donovan K, Nandi G, Patnaik D, et al. Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models. elife. 2019;8: pubmed publisher
  42. Huffman M, Fryszkowska A, Alvizo O, Borra Garske M, Campos K, Canada K, et al. Design of an in vitro biocatalytic cascade for the manufacture of islatravir. Science. 2019;366:1255-1259 pubmed publisher
  43. Reynders M, Matsuura B, Bérouti M, Simoneschi D, Marzio A, Pagano M, et al. PHOTACs enable optical control of protein degradation. Sci Adv. 2020;6:eaay5064 pubmed publisher
  44. Biological Magnetic Resonance Data Bank. Available from: www.bmrb.wisc.edu/
  45. Wise A, Gearing K, Rees S. Target validation of G-protein coupled receptors. Drug Discov Today. 2002;7:235-46 pubmed
  46. Jahnke W, Widmer H. Protein NMR in biomedical research. Cell Mol Life Sci. 2004;61:580-599 pubmed publisher
  47. Vassar R, Bennett B, Babu Khan S, Kahn S, Mendiaz E, Denis P, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286:735-41 pubmed
  48. Efremov I, Vajdos F, Borzilleri K, Capetta S, Chen H, Dorff P, et al. Discovery and optimization of a novel spiropyrrolidine inhibitor of ?-secretase (BACE1) through fragment-based drug design. J Med Chem. 2012;55:9069-88 pubmed publisher
  49. Schellenberg M, Lieberman J, Herrero Ruíz A, Butler L, Williams J, Muñoz Cabello A, et al. ZATT (ZNF451)-mediated resolution of topoisomerase 2 DNA-protein cross-links. Science. 2017;357:1412-1416 pubmed publisher
  50. Fernández C, Jahnke W. New approaches for NMR screening in drug discovery. Drug Discovery Today: Technologies. 2004;1(3):277-83.
  51. Torres F, B xfc tikofer M, Stadler G, Renn A, Kadavath H, Bobrovs R, et al. Ultrafast Fragment Screening Using Photo-Hyperpolarized (CIDNP) NMR. J Am Chem Soc. 2023;145:12066-12080 pubmed publisher
  52. Smolinska A, Blanchet L, Buydens L, Wijmenga S. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta. 2012;750:82-97 pubmed publisher
  53. Zhang J, Wei S, Liu L, Nagana Gowda G, Bonney P, Stewart J, et al. NMR-based metabolomics study of canine bladder cancer. Biochim Biophys Acta. 2012;1822:1807-14 pubmed publisher
  54. Xu X, Huang Y, Wang G, Chen S. Metabolomics: a novel approach to identify potential diagnostic biomarkers and pathogenesis in Alzheimer's disease. Neurosci Bull. 2012;28:641-8 pubmed publisher
  55. Mars R, Yang Y, Ward T, Houtti M, Priya S, Lekatz H, et al. Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome. Cell. 2020;: pubmed publisher
  56. Salek R, Xia J, Innes A, Sweatman B, Adalbert R, Randle S, et al. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem Int. 2010;56:937-47 pubmed publisher
  57. Pavao A, Girinathan B, Peltier J, Altamirano Silva P, Dupuy B, Muti I, et al. Elucidating dynamic anaerobe metabolism with HRMAS 13C NMR and genome-scale modeling. Nat Chem Biol. 2023;19:556-564 pubmed publisher
  58. Zhu H, Barker P. MR Spectroscopy and Spectroscopic Imaging of the Brain. In: Modo M, Bulte JWM, editors. Magnetic Resonance Neuroimaging: Humana Press; 2011. p. 203-26.
  59. van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J. 2010;39:527-40 pubmed publisher
  60. Filippi M, Agosta F, Frisoni G, De Stefano N, Bizzi A, Bozzali M, et al. Magnetic resonance imaging in Alzheimer's disease: from diagnosis to monitoring treatment effect. Curr Alzheimer Res. 2012;9:1198-209 pubmed
  61. Gate D, Saligrama N, Leventhal O, Yang A, Unger M, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. Nature. 2020;577:399-404 pubmed publisher
  62. Brown L, Ladizhansky V. Membrane proteins in their native habitat as seen by solid-state NMR spectroscopy. Protein Sci. 2015;24:1333-46 pubmed publisher
  63. Knight M, Pell A, Bertini I, Felli I, Gonnelli L, Pierattelli R, et al. Structure and backbone dynamics of a microcrystalline metalloprotein by solid-state NMR. Proc Natl Acad Sci U S A. 2012;109:11095-100 pubmed publisher
  64. Demers J, Habenstein B, Loquet A, Kumar Vasa S, Giller K, Becker S, et al. High-resolution structure of the Shigella type-III secretion needle by solid-state NMR and cryo-electron microscopy. Nat Commun. 2014;5:4976 pubmed publisher
  65. Tang M, Nesbitt A, Sperling L, Berthold D, Schwieters C, Gennis R, et al. Structure of the disulfide bond generating membrane protein DsbB in the lipid bilayer. J Mol Biol. 2013;425:1670-82 pubmed publisher
  66. Habenstein B, Loquet A, Hwang S, Giller K, Vasa S, Becker S, et al. Hybrid Structure of the Type 1 Pilus of Uropathogenic Escherichia coli. Angew Chem Int Ed Engl. 2015;54:11691-5 pubmed publisher
  67. Caulkins B, Yang C, Hilario E, Fan L, Dunn M, Mueller L. Catalytic roles of βLys87 in tryptophan synthase: (15)N solid state NMR studies. Biochim Biophys Acta. 2015;1854:1194-9 pubmed publisher
  68. Yan S, Zhang H, Hou G, Ahmed S, Williams J, Polenova T. Internal dynamics of dynactin CAP-Gly is regulated by microtubules and plus end tracking protein EB1. J Biol Chem. 2015;290:1607-22 pubmed publisher
  69. Huang W, Bardaro M, Varani G, Drobny G. Preparation of RNA samples with narrow line widths for solid state NMR investigations. J Magn Reson. 2012;223:51-4 pubmed publisher
  70. Marchanka A, Simon B, Althoff Ospelt G, Carlomagno T. RNA structure determination by solid-state NMR spectroscopy. Nat Commun. 2015;6:7024 pubmed publisher
  71. Paik Y, Yang C, Metaferia B, Tang S, Bane S, Ravindra R, et al. Rotational-echo double-resonance NMR distance measurements for the tubulin-bound Paclitaxel conformation. J Am Chem Soc. 2007;129:361-70 pubmed
  72. Kumar A, Heise H, Blommers M, Krastel P, Schmitt E, Petersen F, et al. Interaction of epothilone B (patupilone) with microtubules as detected by two-dimensional solid-state NMR spectroscopy. Angew Chem Int Ed Engl. 2010;49:7504-7 pubmed publisher
  73. Lu M, Hou G, Zhang H, Suiter C, Ahn J, Byeon I, et al. Dynamic allostery governs cyclophilin A-HIV capsid interplay. Proc Natl Acad Sci U S A. 2015;112:14617-22 pubmed publisher
  74. Morag O, Sgourakis N, Baker D, Goldbourt A. The NMR-Rosetta capsid model of M13 bacteriophage reveals a quadrupled hydrophobic packing epitope. Proc Natl Acad Sci U S A. 2015;112:971-6 pubmed publisher
  75. Lorieau J, Day L, McDermott A. Conformational dynamics of an intact virus: order parameters for the coat protein of Pf1 bacteriophage. Proc Natl Acad Sci U S A. 2008;105:10366-71 pubmed publisher
  76. Shamir Y, Goldbourt A. Atomic-Resolution Structure of the Protein Encoded by Gene V of fd Bacteriophage in Complex with Viral ssDNA Determined by Magic-Angle Spinning Solid-State NMR. J Am Chem Soc. 2023;145:300-310 pubmed publisher
  77. Arboleda Velasquez J, Lopera F, O Hare M, Delgado Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;: pubmed publisher
ISSN : 2329-5139